First Status Conference — In Minnesota District Court — Come January 12, 2016

Kenilworth’s role will likely be slight, in this purported MDL, as it acts merely as a fluoroquinolone distributor, not a manufacturer, if I understand the fact pattern correctly, here. I think (if memory serves) Merck distributes for Bayer, under an old contract — and Avelox® is one of a wide class of fluoroquinolones on market, in the US. My backgrounder here — when this was transferred, from Chicago to Minneapolis — last September.

In any event, here is the new status hearing date — which promises to be a very chilly trip north in January, for anyone headed to the federal District Court in Minneapolis: